Description
Drostanolone Propionate (Masteron) 100 mg Moldavian Pharma
Product Description
Drostanolone Propionate, commonly known as Masteron, is a popular anabolic steroid manufactured by Moldavian Pharma. It is available in a 100 mg dosage form. This product is widely used by athletes and bodybuilders to enhance their performance and achieve their fitness goals.
Specific Details
Drostanolone Propionate is derived from dihydrotestosterone (DHT) and is known for its strong androgenic properties. It has a moderate anabolic effect, making it an ideal choice for individuals looking to improve muscle definition and hardness.
Properties and Benefits
When used correctly, Drostanolone Propionate offers several benefits to athletes and bodybuilders:
- Enhances muscle definition and hardness
- Promotes increased strength and endurance
- Helps in the preservation of lean muscle mass during cutting phases
- Reduces estrogen-related side effects
- Does not convert to estrogen
Possible Side Effects
While Drostanolone Propionate is generally well-tolerated, it may cause some side effects, including:
- Androgenic effects such as acne, oily skin, and increased facial/body hair growth
- Suppression of natural testosterone production
- Potential cardiovascular strain
Usage and Dosage
The recommended dosage of Drostanolone Propionate for beginners is typically 300-400 mg per week, divided into two equal injections. Experienced athletes may increase the dosage to 500-600 mg per week. The cycle duration is usually 6-8 weeks.
Benefits for the Buyer
By purchasing Drostanolone Propionate from our online sports pharmacy, “Anabolicsteroidstablets.com” in England, customers can enjoy the following benefits:
- High-quality product from Moldavian Pharma
- Competitive pricing
- Secure and discreet packaging
- Fast and reliable delivery
- Excellent customer service
Choose “Anabolicsteroidstablets.com” for your Drostanolone Propionate needs and experience the convenience and reliability of our online sports pharmacy.
Reviews
There are no reviews yet.